Skip to main content
Terug
Watch Compare

Pharmagreen Biotech Inc.

Datakwaliteit: 83%
PHBI
OTC Utilities Air Transportation
€ 0,00
€ 0,00 (0,00%)
Marktkapitalisatie: 829.615,0
Prijs
€ 0,00
Marktkapitalisatie
829.615,0
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -138.511,0

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio0,02
Interest Coverage-18,88

Waardering

PE (TTM)
-1,66
Onder sectorgemiddelde (3,70)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Utilities sector mediaan (448 peers)
Metriek Aandeel Sector Mediaan
P/E -1,7 3,7
P/B — 1,6
ROE % — 7,9
Net Margin % — 6,8
Rev Growth 5Y % — 4,2
D/E — 1,0

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -500.710,0
ROE N/A ROA -330,17%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -138.511,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,02
Interest Coverage -18,88 Asset Turnover N/A
Working Capital -2,12 M Tangible Book Value -2,10 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,66 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -16,70%
Market Cap 829.615,0 Enterprise Value 829.615,0
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 27,66%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019
Revenue — — — —
Net Income -875.505,0 -4,53 M -2,44 M -767.537,0
EPS (Diluted) — — — —
Gross Profit — — — —
Operating Income -1,10 M -744.064,0 -485.756,0 -645.961,0
EBITDA — — — —
R&D Expenses — — 3.956,0 3.956,0
SG&A Expenses — — — —
D&A — — — —
Interest Expense 28.780,0 680.714,0 298.942,0 —
Income Tax 0,0 0,0 — —

Balance Sheet

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019
Total Assets 208.971,0 373.081,0 266.245,0 630.272,0
Total Liabilities 2,03 M 2,07 M 3,20 M 1,46 M
Shareholders' Equity -1,82 M -1,69 M -2,89 M -833.224,0
Total Debt — — 30.028,0 —
Cash & Equivalents — 25.300,0 — —
Current Assets — — 266.245,0 189.177,0
Current Liabilities 1,91 M 2,03 M 3,17 M 1,46 M